Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Olesya Y. Gurova"'
Autor:
Ekaterina S. Maloletkina, Olesya Y. Gurova, Valentin V. Fadeyev, Vyacheslav I. Egorov, Roman V. Petrov, Dmitriy G. Beltsevich, Andrei V. Vorob'ev
Publikováno v:
Ожирение и метаболизм, Vol 16, Iss 1, Pp 74-80 (2019)
The prevalence of insulinomas is 1–3 cases per million population per year of which 4–14% tumor is malignant. Weight gain is one of the symptoms of the disease, often resulting in morbid obesity with indications for surgical treatment. The presen
Externí odkaz:
https://doaj.org/article/81317bd25c124c21b67647c28dac788e
Publikováno v:
Сахарный диабет, Vol 21, Iss 6, Pp 524-533 (2018)
In recent years, the options in treatment of diabetes mellitus type 2 have substantially expanded (currently more than 40 molecules are approved), however, the number of patients with decompensation of diabetes for the period from 2003 to 2014 remain
Externí odkaz:
https://doaj.org/article/9a28a6f67134498a832357c1716dc26a
Publikováno v:
Problems of Endocrinology. 66:42-48
This manuscript provides a review of current literature on the relationship between overweight and alexithymia as a psychological factor associated with obesity, as well as the role of alexithymia in the development of various abnormalities and eatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe1b966a73e7e37d11c48e39973101e3
https://doi.org/10.14341/probl12416
https://doi.org/10.14341/probl12416
Autor:
Mir-Masoud Pourrahmat, Khadija Hafidh, Roopa Mehta, Olesya Y. Gurova, Agustina Alvarez, Paul Serafini, Philip Home
Publikováno v:
Diabetes, obesitymetabolism. 23(12)
AIM To assess the efficacy and safety of iGlarLixi, a fixed-ratio combination of basal insulin glargine 100 U/mL and lixisenatide (glucagon-like peptide-1 receptor agonist) versus IDegAsp, a co-formulation of basal insulin degludec 100 U/mL with rapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109210526d0f7dd957aade49dcf15d2f
https://pubmed.ncbi.nlm.nih.gov/34402153
https://pubmed.ncbi.nlm.nih.gov/34402153
Autor:
D. G. Beltsevich, Olesya Y. Gurova, Vyacheslav Egorov, Ekaterina S. Maloletkina, Valentin V. Fadeyev, Andrei V. Vorob'ev, Roman Petrov
Publikováno v:
Ожирение и метаболизм, Vol 16, Iss 1, Pp 74-80 (2019)
The prevalence of insulinomas is 13 cases per million population per year of which 414% tumor is malignant. Weight gain is one of the symptoms of the disease, often resulting in morbid obesity with indications for surgical treatment. The presented cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b42ec60f1dc0f9d2574a8984fca477d3
https://doi.org/10.14341/omet9751
https://doi.org/10.14341/omet9751
Publikováno v:
Сахарный диабет, Vol 21, Iss 6, Pp 524-533 (2018)
In recent years, the options in treatment of diabetes mellitus type 2 have substantially expanded (currently more than 40 molecules are approved), however, the number of patients with decompensation of diabetes for the period from 2003 to 2014 remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49610eaf8efa460e03903daa37e39f10
https://doi.org/10.14341/dm9603
https://doi.org/10.14341/dm9603
Autor:
Philip Home, Olesya Y. Gurova, Roopa Mehta, Mir-Masoud Pourrahmat, Paul Serafini, Khadija Hafidh, Agustina Alvarez
Publikováno v:
Diabetes. 70
Introduction: No head-to-head trials compare iGlarLixi, a fixed-ratio combination of basal insulin (BI) and glucagon-like peptide-1 receptor agonist, with IDegAsp, a co-formulation of BI analog and meal-time insulin. Methods: A systematic literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::893b90d4c26d7b5297ab527e3d0eda3c
https://doi.org/10.2337/db21-118-lb
https://doi.org/10.2337/db21-118-lb
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2538a3f366c20854b806ff7dead4d16d
https://doi.org/10.1530/endoabs.70.aep813
https://doi.org/10.1530/endoabs.70.aep813
Publikováno v:
Russian Open Medical Journal. 10
Bariatric surgery is among successful methods of obesity treatment, with effects going beyond weight reduction alone, but rather involving improved glucose tolerance, along with control or remission of the type 2 diabetes mellitus. The precise mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5098712630b7f69f2208a348f83c0b8c
https://doi.org/10.15275/rusomj.2021.0112
https://doi.org/10.15275/rusomj.2021.0112
Autor:
Home, Philip D., Mehta, Roopa, Hafidh, Khadija A. S., Gurova, Olesya Y., Alvarez, Agustina, Serafini, Paul, Pourrahmat, Mir‐Masoud
Publikováno v:
Diabetes, Obesity & Metabolism; Dec2021, Vol. 23 Issue 12, p2660-2669, 10p